Prognostic impact of rapid involved light chain reduction in first line therapy with Bendamustine, Prednisone and Bortezomib (BPV) in myeloma patients
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI